(Q44041707)
Statements
Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients (English)
P P H Le Brun
A H de Boer
G P M Mannes
D M I de Fraîture
R W Brimicombe
D J Touw
A A Vinks
H G M Heijerman